Human Subjects Research in Bioemergencies
Bioemergencies present unique ethical and operational challenges to performing clinical research with human subjects. Patient care, public health protection, and responder safety are paramount in these situations, which often involve high biosafety level pathogens and containment conditions. While working to halt the spread of disease, research is necessary to understand the ongoing outbreak as well as increase response capabilities in the face of future threats. Research in bioemergencies has novel and unexpected challenges that vary greatly depending on the type of studies being conducted and data being collected. This chapter will provide an understanding of basic principles, challenges, and regulatory components of human subjects research during bioemergencies, as well as ongoing practical components of these studies.
KeywordsResearch Ethics Novel pathogen Clinical trial Biorepository Institutional review board Human subjects research Publication Data Public health Confidentiality
- 2.Human Subject Regulations Decision Charts [Internet]. HHS.gov. 2017 [cited 29 October 2017]. Available from: https://www.hhs.gov/ohrp/regulations-and-policy/decision-charts/index.html. eCFR — Code of Federal Regulations [Internet]. Ecfr.gov. 2017 [cited 29 October 2017]. Available from: https://www.ecfr.gov/cgi-bin/ECFR?page=browse
- 3.Protection of Human Subjects, 45 C.F.R. §46 (2009). [regulation on the Internet]. [cited 29 October 2017]. Available from: https://www.ecfr.gov/cgi-bin/text-idx?tpl=/ecfrbrowse/Title45/45cfr46_main_02.tpl.
- 4.Mack A, Choffnes ER, Sparling PF, Hamburg MA, Lemon SM, editors. Ethical and legal considerations in mitigating pandemic disease: workshop summary. In: National Academies Press. Washington, DC; 2007.Google Scholar
- 5.Protection of Human Subjects, 21 C.F.R. §50.23 (2017). [regulation on the Internet]. [cited 29 October 2017]. Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=50.23.
- 6.Protection of Human Subjects, 21 C.F.R. §50.24 (2017). [regulation on the Internet]. [cited 29 October 2017]. Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=50.
- 7.Investigational New Drug (IND) Application [Internet]. Fda.gov. 2017 [cited 29 November 2017]. Available from: https://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/InvestigationalNewDrugINDApplication/default.htm.
- 8.Protection of Human Subjects, 21 C.F.R. §56.104c (2017). [regulation on the Internet]. [cited 29 October 2017]. Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=56.104.
- 9.Emergency Use Authorization of Medical Products and Related Authorities Guidance for Industry and Other Stakeholders [Internet]. Fda.gov. 2017 [cited 29 November 2017]. Available from: https://www.fda.gov/downloads/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/MCMLegalRegulatoryandPolicyFramework/UCM493627.pdf.
- 10.Schopper D, Dawson A, Upshur R, Ahmad A, Jesani A, Ravinetto R, Segelid MJ, Sheel S, Singh J. Innovations in research ethics governance in humanitarian settings. BMC Med Ethics 2015;16(1):10.Google Scholar
- 11.Altevogt B, Wizemann T, Reeve M, editors. Enabling Rapid and Sustainable Public Health Research During Disasters: Summary of a Joint Workshop by the Institute of Medicine and the US Department of Health and Human Services. Chapter 4: Addressing Institutional Review Board Barriers to Health Research Implementation.Washington, DC: National Academies Press; 2015.Google Scholar
- 12.National Ebola Training and Education Center [Internet]. NETEC. 2017 [cited 29 October 2017]. Available from: https://netec.org
- 13.NCATS Streamlined, Multisite, Accelerated Resources for Trials (SMART) IRB Reliance Platform. National Center for Advancing Translational Sciences (NCATS). October 14, 2016. (Retrieved from: https://ncats.nih.gov/expertise/clinical/smartirb).
- 16.Coded Private Information or Specimens Use in Research, Guidance (2008) [Internet]. HHS.gov. 2008 [cited 29 October 2017]. Available from: https://www.hhs.gov/ohrp/regulations-and-policy/guidance/research-involving-coded-private-information/index.html.
- 18.Guidelines and Policies for the Conduct of Research in the Intramural Research Programs at the NIH [Internet]. oir.nih.gov. 2015 [cited 29 October 2017]. Available from: https://oir.nih.gov/sites/default/files/uploads/sourcebook/documents/ethical_conduct/guidelines-conduct_research.pdf.
- 19.Horn EJ, Moore HM. Overcoming challenges in the acquisition of biospecimens for rare diseases. Expert Opin Orphan Drugs. 2013;2(1):1–4.Google Scholar
- 22.Developing global norms for sharing data and results during public health emergencies [Internet]. World Health Organization. 2015 [cited 29 October 2017]. Available from: http://www.who.int/medicines/ebola-treatment/blueprint_phe_data-share-results/en/.